High frequency of oncogenic BRAF mutations has important clinical implications and multiple studies have shown that BRAFV600E correlates with aggressive features of thyroid cancer such as extrathyroidal extensions, vascular invasion, larger thyroid nodule size, advanced staging, lymph node metastasis and recurrence (77). This evidence concerns the gene BRAF and thyroid gland carcinoma.